Patient-derived bladder cancer organoid model to predict sensitivity and feasibility of tailored precision therapy

BACKGROUND: Bladder cancer is a common and highly heterogeneous malignant tumor with a relatively poor prognosis. Thus, personalized treatment strategies for bladder cancer are essential for improving patient outcomes. MATERIALS AND METHODS: We developed an efficient 3-dimensional in vitro organoid...

Descripción completa

Detalles Bibliográficos
Autores principales: Jiang, Ying, Sun, Xun, Song, Xiaoyun, Li, Zhen, Zhang, Ping, Zhang, Wen, Tang, Dongqi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Special Topic - Advances in Bladder Cancer Therapy
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10662868/
https://www.ncbi.nlm.nih.gov/pubmed/37994334
http://dx.doi.org/10.1097/CU9.0000000000000219

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10662868/
https://www.ncbi.nlm.nih.gov/pubmed/37994334
http://dx.doi.org/10.1097/CU9.0000000000000219

Ejemplares similares